In ovarian cancer, miR-1307 was up-regulated in the chemoresistant epithelial ovarian cancer tissues and might play a role in the development of chemoresistance in ovarian cancer by targeting DAPK3 (Zhou et al., 2015) (Table 1; Figure 3). The gene discussed is DAPK3; the disease is ovarian carcinoma.